This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Western University directory, so their courses may be missing. Find their university profile.
Research
Read how they describe their research on their Western University profile.
Latest papers
Evaluation for the Presence of SARS-CoV-2 in CO2 Laser Plume
Journal of Otolaryngology - Head and Neck Surgery · 2025
SARS-CoV-2 viral titer measurements in Ontario, Canada wastewaters throughout the COVID-19 pandemic.
Scientific data · 2024
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Vaccines · 2024
Latest funding
- $200,000
Packing HIV-like particles with a punch for a cure
CIHR · 2024 · Nominated PI
- $2,000,000
Targeted Therapeutics for HIV-1 Cure
CIHR · 2024 · Nominated PI
- $1,162,800
Development of an HIV-1 vaccine with enhanced CD4 engagement and inducing broadly neutralizing antibodies
CIHR · 2024 · Nominated PI
7 publications.
Evaluation for the Presence of SARS-CoV-2 in CO2 Laser Plume
Bysice A, Gibson R, Moore C, Sommer DD, Nichols A, Arts E, Sowerby LJ
SARS-CoV-2 viral titer measurements in Ontario, Canada wastewaters throughout the COVID-19 pandemic.
D'Aoust PM, Hegazy N, Ramsay NT, Yang MI, Dhiyebi HA, Edwards E, Servos MR, Ybazeta G, Habash M, Goodridge L, Poon A, Arts E, Brown RS, Payne SJ, Kirkwood A, Simmons D, Desaulniers JP, Ormeci B, Kyle C, Bulir D, Charles T, McKay RM, Gilbride K, Oswald C, Peng H, Pileggi V, Wang ML, Tong A, Orellano D, WSI Consortium, DeGroot CT, Delatolla R
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, Racine T, Kang CY, Gaillet B, Garnier A, Gilbert R, Kamen A, Yao XJ, Fowke KR, Arts E, Kobinger G
"…So that's why we hide, we don't want them to know"- Challenges to Antiretroviral Therapy Adherence in Kampala, Uganda.
Bruser G, Luginaah I, Katasi R, Zhang LZ, Namasinga M, Kityo C, Arts E
Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.
Jelinski J, Kowatsch MM, Lafrance MA, Berger A, Pedersen J, Azizi H, Li Y, Scholte F, Gomez A, Hollett N, Le T, Wade M, Fausther-Bovendo H, de La Vega MA, Babuadze G, Xiii A, Lamarre C, Racine T, Kang CY, Yao XJ, Alter G, Arts E, Fowke KR, Kobinger GP
Failure is not an option: Barriers to HIV treatment adherence in Kampala, Uganda.
Bruser G, Katasi R, Zhang LZ, Namasinga M, Arts E, Kityo C, Luginaah I
Assessing the Risk of SARS-CoV-2 Transmission via Surgical Electrocautery Plume
Sowerby LJ, Nichols AC, Gibson R, Sommer DD, Moore C, Fraser DD, Arts E
Packing HIV-like particles with a punch for a cure
Principal investigators: Arts, Eric J
Keywords: Cure; Hiv-1; Rna Adjuvant; Therapeutic
Targeted Therapeutics for HIV-1 Cure
Principal investigators: Arts, Eric J; Walmsley, Sharon L; Dikeakos, Dimitrios J; Lavender, Kerry J
Keywords: Cure; Hiv-1; Humanized Mice; Marginalized Populations; Therapeutic
Development of an HIV-1 vaccine with enhanced CD4 engagement and inducing broadly neutralizing antibodies
Principal investigators: Arts, Eric J
Keywords: Antibody; B Cells; Hiv; Vaccine
Canada Research Chair - Tier 1
Principal investigators: Arts, Eric J
Keywords: Crc
COVID-19 Variant Supplement - Shutting down emerging Coronaviruses in humans now and in the future
Principal investigators: Barr, Stephen D; Arts, Eric J; Kang, Chil Yong; Troyer, Ryan
Keywords: Coronavirus; Immunity; Infection; Mouse Model; Pathogenesis; Reverse Genetics; Vaccine; Viral Replication
Evidence-based guidance for mitigating COVID-19 virus droplet transmission and surface contamination_x000d_ _x000d_
Principal investigators: Savory, Eric
Shutting down emerging Coronaviruses in humans now and in the future
Principal investigators: Barr, Stephen D; Arts, Eric J; Kang, Chil Yong; Troyer, Ryan
Keywords: Coronavirus; Immunity; Infection; Mouse Model; Pathogenesis; Reverse Genetics; Vaccine; Viral Replication
Sex as a Biological Variable Supplement - Shutting down emerging Coronaviruses in humans now and in the future
Principal investigators: Barr, Stephen D; Arts, Eric J; Kang, Chil Yong; Troyer, Ryan
Keywords: Coronavirus; Immunity; Infection; Mouse Model; Pathogenesis; Reverse Genetics; Vaccine; Viral Replication
Presence of viable SARS-CoV-2 virus in surgical smoke produced during electrocautery
Principal investigators: Sowerby, Leigh J
Keywords: Aerosol; Aerosol Generating Medical Procedure; Electrocautery; Plume; Rt-Pcr; Sars-Cov-2; Surgery; Surgical Smoke
Developing the ACT-VEC as an HIV therapeutic vaccine and cure approach
Principal investigators: Arts, Eric J
Keywords: Hiv
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Microbiology and Immunology
- Surgery
- Health Studies
- Bioengineering
- Department of Otolaryngology - Head and Neck Surgery
- PATHOLOGY & LABORATORY MEDICINE, Western University
- Génie chimique
- Other
Co-authors at Western University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Isaac Luginaah
Health Studies
2 shared papers, latest 2024
Doron Sommer
Surgery
2 shared papers, latest 2025
Amine Kamen
Bioengineering
1 shared papers, latest 2024
Robert Delatolla
Civil Engineering
1 shared papers, latest 2024
Hui Peng
Faculty
1 shared papers, latest 2024
Denina Simmons
Faculty
1 shared papers, latest 2024
Art Poon
PATHOLOGY & LABORATORY MEDICINE, Western University
1 shared papers, latest 2024
Xiao-Jian Yao
Medical Microbiology and Infectious Diseases
1 shared papers, latest 2023
Bruno Gaillet
Génie chimique
1 shared papers, latest 2024
Anthony Nichols
Department of Otolaryngology - Head and Neck Surgery
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.